Adrenergic, beta-2-, Receptor, Surface (ADRB2) (Middle Region) Peptide
Quick Overview for Adrenergic, beta-2-, Receptor, Surface (ADRB2) (Middle Region) Peptide (ABIN5672831)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- RQLQKIDKSE GRFHVQNLSQ VEQDGRTGHG LRRSSKFCLK EHKALKTLGI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- ADRB2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
-
Background
-
This gene encodes beta-2-adrenergic receptor which is a member of the G protein-coupled receptor superfamily. This receptor is directly associated with one of its ultimate effectors, the class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. The assembly of the signaling complex provides a mechanism that ensures specific and rapid signaling by this G protein-coupled receptor. This gene is intronless. Different polymorphic forms, point mutations, and/or downregulation of this gene are associated with nocturnal asthma, obesity and type 2 diabetes.
Alias Symbols: BAR, B2AR, ADRBR, ADRB2R, BETA2AR
Protein Size: 413 -
Gene ID
- 154
-
NCBI Accession
- NM_000024, NP_000015
-
UniProt
- P07550
Target
-